Literature DB >> 30176611

Revealing Clusters of Connected Pathways Through Multisource Data Integration in Huntington's Disease and Spastic Ataxia.

Andrea C Kakouri, Christiana C Christodoulou, Margarita Zachariou, Anastasis Oulas, George Minadakis, Christiana A Demetriou, Christina Votsi, Eleni Zamba-Papanicolaou, Kyproula Christodoulou, George M Spyrou.   

Abstract

The advancement of scientific and medical research over the past years has generated a wealth of experimental data from multiple technologies, including genomics, transcriptomics, proteomics, and other forms of -omics data, which are available for a number of diseases. The integration of such multisource data is a key component toward the success of precision medicine. In this paper, we are investigating a multisource data integration method developed by our group, regarding its ability to drive to clusters of connected pathways under two different approaches: first, a disease-centric approach, where we integrate data around a disease, and second, a gene-centric approach, where we integrate data around a gene. We have used as a paradigm for the first approach Huntington's disease (HD), a disease with a plethora of available data, whereas for the second approach the GBA2, a gene that is related to spastic ataxia (SA), a phenotype with sparse availability of data. Our paper shows that valuable information at the level of disease-related pathway clusters can be obtained for both HD and SA. New pathways that classical pathway analysis methods were unable to reveal, emerged as necessary "connectors" to build connected pathway stories formed as pathway clusters. The capability to integrate multisource molecular data, concluding to something more than the sum of the existing information, empowers precision and personalized medicine approaches.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30176611     DOI: 10.1109/JBHI.2018.2865569

Source DB:  PubMed          Journal:  IEEE J Biomed Health Inform        ISSN: 2168-2194            Impact factor:   5.772


  3 in total

1.  Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15).

Authors:  Vasiliki Gkretsi; Maria Louca; Andreas Stylianou; George Minadakis; George M Spyrou; Triantafyllos Stylianopoulos
Journal:  Int J Mol Sci       Date:  2019-01-04       Impact factor: 5.923

2.  PathwayConnector: finding complementary pathways to enhance functional analysis.

Authors:  George Minadakis; Margarita Zachariou; Anastasis Oulas; George M Spyrou
Journal:  Bioinformatics       Date:  2019-03-01       Impact factor: 6.937

3.  Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington's Disease Status Based on Omics Data.

Authors:  Christiana C Christodoulou; Margarita Zachariou; Marios Tomazou; Evangelos Karatzas; Christiana A Demetriou; Eleni Zamba-Papanicolaou; George M Spyrou
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.